Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
West Pharmaceutical Services ( (WST) ) just unveiled an announcement.
West Pharmaceutical Services has elected Janet Haugen, former CFO of Unisys Corporation, to its Board of Directors, expanding the board to 12 members. Haugen’s extensive experience in finance and technology is expected to strengthen West’s leadership, enhancing its capability to deliver healthcare solutions to millions of patients globally.
More about West Pharmaceutical Services
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, supporting drug developers with the safe and effective delivery of medicines. Headquartered in Exton, Pennsylvania, West generated $2.95 billion in net sales in fiscal year 2023 and employs 10,000 team members across 50 sites worldwide.
YTD Price Performance: -9.11%
Average Trading Volume: 602,570
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $23.12B
For an in-depth examination of WST stock, go to TipRanks’ Stock Analysis page.
